Abstracts CPOCT Symposium

AACC CPOCT International Symposium

The Benefits and Challenges of Point-of-Care Testing Across the Clinical Spectrum
September 21-24, 2016, Copenhagen, Denmark
Accepted Abstracts

Poster                   Submitting Author/Title                              

Session 1:  POCT in the Intensive Care Setting

P1  Allon Reiter: Diagnosis of Infection Utilizing Accellix CD64

P2  Paloma Oliver:  Precision and agreement of 266 strip-based glucose meters without the involvement of the laboratory medicine

P3  Hanneke Buter: Plasma glutamine levels before cardiac surgery are related to post-surgery infections; an observational study.

P4  Nuha Al Humaidan: Analytical Performance of Point of Care Blood Gas Analyzers In The Operating Theaters

P5  Zachary O'Brien: Novel POC Devices for Testing Procalcitonin (PCT) in ER and ICU Settings

P6  James Nichols: GEM Premier 5000 Clinical Evaluation

P7  Gareth Davies: Development of an External Quality Assessment Scheme for POCT Creatinine Whole Blood Meters

P8  Alex Mewis: Organization of an external Quality Control Program for ACT Medtronic

P9  Paloma Oliver: Differences in blood gas results between POCT Neonatal Intensive Care Unit and Emergency laboratory

P10  Jose Cervera: Evaluation of Precision Performance on GEM Premier 5000 with iQM2 Blood Gas Analyzers

P11  Paul Holloway: Evaluating a novel ex-vivo point-of-care testing device for blood gas and electrolyte measurement for acceptance by the POCT committee

P12  Nichole Korpi-Steiner: GEM Premier 5000 Analytical Evaluation at the University of North Carolina

P13  Nicole Brooks: POCT Utilization for Improved Patient Care in the Neonatal Intensive Care Unit using the GEM 4000

P14  Paul Yip: Can an Accreditation Compliant POCT Coagulation Program Be Implemented Successfully in the Cardiac Operating Room Setting?

P15  Masaru Yamamoto: Analytical Evaluation of New Combined POC Blood Glucose/Ketone Monitoring System

P16  Masaru Yamamoto: Analytical Considerations When Selecting Laboratory Reference Reagents for Routine Use and for Evaluating POC Blood Ketone Monitoring Systems

P17  Najwa Adlan: Evaluation of the appropriateness of implementing Point of Care Testing in KFSHRC Oncology Clinics

P18  Linda Iorizzo: Stat-strip Express- a possible handheld poc for lactate testing in fetal blood sampling during labour?

P19  Leslie Donato: Point of Care Glucose Accuracy in Surgical Patients under Anesthesia

P20  Najwa Adlan: Planning and implementation the Individualized Quality Control Plan for Coagulation Testing done in Critical Care area in KFSHRC

P21  Keita Yamashita: Assessment of Diagnosis for Diabetic Ketoacidosis Using StatStrip Blood 3-Hydroxybutyrate Meter

P22  Charbel Abou-Diwan: Multi-Site Evaluation of Three Blood Glucose Measurement Systems

P23  Michel Vaubourdolle: GEM Premier 5000 (Werfen): analyzer evaluation, risk assessment and practicability

Session 2:  Direct to Consumer Testing

P24  Victor Olagundoye: The effectiveness of fetal Lactate measurement in the assessment of fetal acidaemia using StatStrip Lactate® meter

P25  Yong He: The variation of multiple-department POCT blood gas analyzers

P26  Hong Jiang: Building the network management of POCT of blood gas analysis

P27  Marion Fokkert: Concordance assessment of StatSensor Creatinine compared to a Central Laboratory enzymatic method for identifying chronic kidney disease stages 3-5 (eGFR <60 ml/min/1.73m)

P28  Qinwei Shi: A new one-step direct-sampling HIV antibody rapid test

P29  Julie Jacobs: Commutability of external quality material for blood glucose measuring systems

P30  Jin Xu: The Importance of using NIST calibration when selecting a laboratory reference method for evaluating POC Blood Glucose Monitoring Systems

P31  Jin Xu: Assessment of the performance of Blood Glucose Monitoring Systems for monitoring dysglycaemia in neonatal patients

Session 3:  POCT in the Primary Care Setting

P32  Eunhee Nah: Clinical Value of the Urinary Albumin-to-Creatinine Ratio Measured Using a Strip Test in Prediabetes and diabetes

P33  Kirsi Luttinen-Maunu: Nurse-managed Anticoagulation Clinic in Finland--How Point-of-care testing (POCT) affects TTR in Primary Care Setting

P34  Maurice Laville: Creatinine level in capillary blood: a new tool for instant estimation of glomerular filtration rate at home or in ambulatory care settings

P35  Marijana Vucic Lovrencic: Diagnostic performance of a point-of-care glucose analyzer in gestational diabetes

P36  Sanne van Delft: Analytical performance, agreement, and user-friendliness of automated POCT urine test strip analysers, and a comparison between man and machine

P37  Kirsi Luttinen-Maunu: Quality Management of Point-of-care testing (POCT) process in nurse-managed anticoagulation clinics

P38  Ayssar Elamin: Tuberculosis POCT: An Integrated Photonic Biosensor for Tuberculosis Detection

P39  Lara Harmans: Implementation of quality assured POC testing in Dutch general practice

P40  Hans van Pelt: Evaluation of three POCT Hematology analyzers for white blood cell analysis

P41  Celine van Lint: Self-monitoring creatinine after kidney transplantation: adherence to measurement protocol and reliability of patient reported data

P42  Anjly Jain: Point of care creatinine testing in screening and monitoring of chronic kidney disease

P43  Javier Segarra: New Emergency departments in primary care, efficiency when enhancing the role of POCT

P44  Najwa Adlan: POC Cholestrol in different Health Care settings

P45  William Nelson: The T-COR 8™ System for Point-of-Care Multiplex Real Time Polymerase Chain Reaction (RT-PCR) Assays Directly from Patient Samples

P46  Noorjehan Joonas: Evaluation of the Roche B101 HbA1c point of Care Analyzer

P47  Violeta Stojkovic: Evaluation of estimated GFR using a point of care (POC) measure of creatinine in patients with iohexol determinate GFR

P48  Annika Eriksson: Evaluation of the HemoCue HbA1c 501 system in primary care settings

P75  Dorra Arvanitis:  Interference verification of the ABL827 point-of-care creatinine method compared to automated creatinine assays

Session 4:  POCT in the Pediatric Setting

P49  Tanya Gill: Home ketone monitoring in Glycogen Storage Disorder type 0, III, VI and IX

P50  Julie Shaw: Analytical evaluation of a POC lactate meter for measurement of fetal scalp lactate concentrations intrapartum

P51  Cindy Knudsen: POCT Instruments in pediatric ambulances: What to consider

P52  Clare Bailey: Independent validation of the use of point-of-care (POC) lactate in addition to POC pH for the clinical determination of foetal distress and associated surgical intervention

P53  Katrina Crawford: POCKET: Feasibility of the use of Point of Care Technology to Measure Ketone and Lactate levels in the Newborn at Risk from Hypoglycaemia

Session 5:  POCT in the Emergency Department

P54  Jesper Eugen-Olsen: Introducing fast measurement of suPAR in the Emergency Department using Lateral Flow Technology

P55  Christine Snozek: We Want POCT…but we don’t trust it: managing the disconnect between providers’ perceived needs and actual acceptance of point-of-care testing in the emergency department and hospital

P56  Ayesha Heinis: Clinical evaluation of Statstrip® Lactate for use in fetal scalp blood sampling

P57  Jen-Shiou Lin: Comparison of the Alere i Influenza System with the Sofia analyzer for rapid detection of influenza A and B viruses in patients presenting with acute flu-like symptoms

P58  Sarah Vandamme: Validation of the NOVA POCT StatStrip β--ketone test in a laboratory and clinical setting

P59  Malak Al Mashali: The interobserver reliability of a novel qualitative point of care assay for heart-type fatty acid binding protein

P60  Pamela Frank: Evaluation of the Next Generation i-STAT® Point-of-Care Instrument using a Sodium Test

P61  Annelie Brolinson: Preliminary evaluation of a new method for quality assurance by instant detection of hemolysed blood samples at the point-of-care

P62  Jacqueline Klein Gunnewiek: Validation of a Point-of-Care Testing ionized magnesium analyser

P63  Jacqueline Klein Gunnewiek: Influence of physical exercise on ionized and total magnesium concentrations in athletes

P64  Qinwei Shi: A rapid H-FABP test for qualitative measurement of H-FABP in serum, plasma and whole blood

P65  Pradeep Apte: A comprehensive profile for the diagnosis of Dengue in an emergency setting

P66  Chin-Pin Yeo: Expanding Needs for Point of Care Testing (POCT): Reviews, Evaluations, Updates

P67  Femke Theije: Performance evaluation of the Philips Minicare cTnI assay

P68  Alex Mewis: Analytical evaluation of the Aspect-Plus ST2 test, a lateral flow immunoassay: is the clinical cut-off still acceptable?

P69  Evangelos Ntrivalas: Case report - clinical utility of point-of-care testing in laboratory information system (LIS) emergency conditions

P70  Grigoris Karamasis: Impact of point-of-care creatinine and eGFR measurements on the risk of contrast-induced acute kidney injury for patients with ST segment elevation myocardial infarction undergoing primary PCI

P71  Julie Jacobs: Analytical performance assessment of two POC ketone assays

P72  Nam Tran: Prospective Observational Study of Point-of-care Creatinine Testing in Adult Trauma

P73  Nam Tran: Clinical Value of Point-of-Care Lactate in Adult Patients with Sepsis

P75  Dorra Arvanitis:  Interference verification of the ABL827 point-of-care creatinine method compared to automated creatinine assays

P76 Jenny Andrea Carmona: POCT reduces TAT in laboratory tests of an emergency department in Colombia